X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Panacea Biotech Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Panacea Biotech Quarterly Results   (PANB)

Here are the latest quarterly results of Panacea Biotech. For more details, see the Panacea Biotech financial fact sheet and Panacea Biotech share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Panacea Biotech Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,0321,2371,3721,0221,6701,0761,5261,522 
Other income Rs m8611220013774121819 
Turnover Rs m2,1171,3491,5721,1591,7441,0891,5441,541 
Expenses Rs m9771,1291,2691,0241,1931,1491,1571,219 
Gross profit Rs m1,055107103-2563854413451 
Depreciation Rs m170166166165161144144145 
Interest Rs m243250255263246259265251 
Profit before tax Rs m727-197-118-2932304632274 
Tax Rs m500025173423 
Profit after tax Rs m722-197-118-293206447-1251 
Gross profit margin %51.98.77.5-0.233.779.327.129.6 
Effective tax rate %0.70.00.00.010.73.6154.831.4 
Net profit margin %35.5-15.9-8.6-28.612.341.5-0.83.3 
Diluted EPS Rs 11.8 -3.2 -1.9 -4.8 3.4 7.3 -0.2 0.8  
Diluted EPS (TTM) Rs 5.8 8.6 9.5 1.9 -6.6 3.9 5.7 11.3  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare PANACEA BIOTECH With:   BIOCON LTD  ALKEM LABORATORIES  TORRENT PHARMA  DR. REDDYS LAB  ALEMBIC PHARMA  

Compare PANACEA BIOTECH With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Volatile Day Flat; Auto Stocks Top Gainers(Closing)

After opening the day in green, share markets in India witnessed volatile trading activity throughout the day and ended the day on a positive note.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


May 22, 2018 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH - TEVA PHARMA COMPARISON

COMPARE PANACEA BIOTECH WITH

MARKET STATS